thiorphan has been researched along with Chronic Kidney Failure in 2 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dussaule, JC | 1 |
| Michel, C | 1 |
| Peraldi, MN | 1 |
| Lecomte, JM | 1 |
| Gros, C | 1 |
| Mignon, F | 1 |
| Ardaillou, R | 1 |
| Hand, MF | 1 |
| Haynes, WG | 1 |
| Webb, DJ | 1 |
2 trials available for thiorphan and Chronic Kidney Failure
| Article | Year |
|---|---|
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cyclic GMP; Double-Blind Method; Female; | 1993 |
Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
Topics: Adult; Endothelin Receptor Antagonists; Endothelin-1; Female; Forearm; Glycopeptides; Humans; Inject | 1999 |